Kala Bio (KALA) Non-Current Assets (2016 - 2025)
Kala Bio (KALA) recorded Non-Current Assets of $747,000 in Q3 2025, down 73.3% from $2.8 million a year earlier and down 68.7% from the prior quarter.
Powered by 
Analysis
Kala Bio (KALA) Non-Current Assets (2016 - 2025) Analysis & Trends
At the end of FY2024, Kala Bio reported Non-Current Assets of $2.69 million, down 12.8% from FY2023.
- Annual Non-Current Assets has a five-year compound annual growth rate of -44.0% (FY2019 to FY2024).
- Across earlier years, Non-Current Assets came in at $3.08 million in FY2023 (+250.7%), $878,000 in FY2022 (-94.2%), $15.06 million in FY2021 (-70.0%) and $50.23 million in FY2020 (+2.8%).
- The Q3 2025 figure is the lowest quarterly Non-Current Assets since Q2 2017.
- On a year-over-year basis, Non-Current Assets has declined for five consecutive quarters, with growth averaging 68.0% over the last eight quarters.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 250.7% in Q4 2023, against a decline of 97.7% in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.39 million (Q2 2025), $2.54 million (Q1 2025) and $2.69 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 82.81 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 110.20 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 75.00 Mn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 88.47 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 61.69 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 34.86 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 159.99 Bn |
| 10 | Kala Bio | 2.38 Mn | -42.27 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 747,000.00 |
| Jun 30, 2025 | 2.39 Mn |
| Mar 31, 2025 | 2.54 Mn |
| Dec 31, 2024 | 2.69 Mn |
| Sep 30, 2024 | 2.80 Mn |
| Jun 30, 2024 | 2.75 Mn |
| Mar 31, 2024 | 2.95 Mn |
| Dec 31, 2023 | 3.08 Mn |
| Sep 30, 2023 | 3.22 Mn |
| Jun 30, 2023 | 965,000.00 |
| Mar 31, 2023 | 882,000.00 |
| Dec 31, 2022 | 878,000.00 |
| Sep 30, 2022 | 1.03 Mn |
| Jun 30, 2022 | 1.46 Mn |
| Mar 31, 2022 | 13.32 Mn |
| Dec 31, 2021 | 15.06 Mn |
| Sep 30, 2021 | 44.73 Mn |
| Jun 30, 2021 | 43.74 Mn |
| Mar 31, 2021 | 50.76 Mn |
| Dec 31, 2020 | 50.23 Mn |
API Access
Kala Bio Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=KALA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "KALA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=KALA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();